"Investing in innovation for underserved populations saves lives." October 19, 2021 -- In 2014, Dr. Umut Gurkan, associate professor in the Case Western Reserve University School of Engineering, ...
NEW YORK and LONDON, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today ...
Urticaria is treated with intravenous dexamethasone 10 mg and intravenous diphenhydramine 25 mg and resolves rapidly. She is dismissed home and continues with cetirizine 10 mg twice daily and ...
The presentation served as a core example of the conference’s commitment to "Evidence-Based Traditional Medicine," ...
NEW YORK and LONDON, April 03, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today ...
A new case study in the journal Case Reports in Medicine emphasizes that a broad differential diagnosis for fever should be considered after a patient with an elevated fever and rigidity was ...
The Clinical and Translational Science Collaborative encourages collaboration across partner institutions and community organizations. We offer support to enhance multisite research efficiency and ...
How can we teach our physiotherapy students to think like professionals when the honest answer is “it depends”? Using case ...
A case study appearing in the journal Pharmacotherapy describes a patient with no significant medical history who developed severe acute liver injury, likely from use of a bodybuilding supplement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results